This group recognizes that there may be significant barriers to safe NTM-RTV use in SOTRs on tacrolimus and recommends a greater focus on local strategies that allow coordinated access to remdesivir and monoclonal antibodies as first-line therapy in this patient population.
← all excerpts
Supratherapeutic Tacrolimus Concentrations With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients Requiring Hospitalization: A Case Series Using Rifampin for Reversal.
1
—
—